Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124917) titled 'A single-arm phase II clinical trial to explore the efficacy and safety of neoadjuvant intermediate fractionated radiotherapy combined with chemotherapy in patients with stage II-III soft tissue sarcoma' on May 19.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Peking University Cancer Hospital
Condition:
Soft tissue sarcoma
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2025-09-10
Target Sample Size: treatment group:89;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=274780
Disclaimer: Curated by HT...